EUVIMEDEUVIMED entdecken
Open Access

Mapping SARS-CoV-2 antigenic relationships and serological responses

Samuel H Wilks iD, Barbara Mühlemann iD, Xiaoying Shen iD, Sina Türeli, Eric B LeGresley iD, Antonia Netzl iD, Miguela A Caniza iD, Jesus N Chacaltana-Huarcaya iD, Victor M Corman iD, Xiaoju Daniell iD, Michael B Datto iD, Fatimah S Dawood und 20 weitere

Science · 06.10.2023 · 382 (6666)

DOI: 10.1126/science.adj0070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 06.10.2023. Verfasst von Samuel H Wilks und 31 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Spike Glycoprotein, Coronavirus, Antigens, Viral. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, multiple variants escaping preexisting immunity emerged, causing reinfections of previously exposed individuals. Here, we used antigenic cartography to analyze patterns of cross-reactivity among 21 variants and 15 groups of human sera obtained after primary infection with 10 different variants or after messenger RNA (mRNA)–1273 or mRNA-1273.351 vaccination. We found antigenic differences among pre-Omicron variants caused by substitutions at spike-protein positions 417, 452, 484, and 501. Quantifying changes in response breadth over time and with additional vaccine doses, our results show the largest increase between 4 weeks and >3 months after a second dose. We found changes in immunodominance of different spike regions, depending on the variant an individual was first exposed to, with implications for variant risk assessment and vaccine-strain selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Spike Glycoprotein, CoronavirusAntigens, ViralmRNA VaccinesHumansAntibodies, NeutralizingAntibodies, ViralCross ReactionsVaccinationAmino Acid Substitution

Substanzen

Antibodies, NeutralizingAntibodies, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Antigens, ViralmRNA Vaccines

Autor:innen und Institutionen

  • Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK.
  • Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
  • German Centre for Infection Research (DZIF), partner site Charité, 10117 Berlin, Germany.
  • Department of Surgery, Duke University School of Medicine, Durham, NC, USA.
  • Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Department of Global Pediatric Medicine, Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.

ORCID-Profile: Samuel H Wilks, Barbara Mühlemann, Xiaoying Shen, Eric B LeGresley, Antonia Netzl, Miguela A Caniza, Jesus N Chacaltana-Huarcaya, Victor M Corman, Xiaoju Daniell, Michael B Datto, Christian Drosten, Ron A M Fouchier, Patricia J Garcia, Peter J Halfmann, Lara M Jeworowski, Terry C Jones, Yoshihiro Kawaoka, Florian Krammer, Charlene McDanal, Rolando Pajon, Viviana Simon, Melissa S Stockwell, Harm van Bakel, Vic Veguilla, Richard Webby, David C Montefiori, Derek J Smith

Förderung

  • NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Wilks, S. H., Mühlemann, B., Shen, X., Türeli, S., LeGresley, E. B., Netzl, A., Caniza, M. A., Chacaltana-Huarcaya, J. N., Corman, V. M., Daniell, X., Datto, M. B., Dawood, F. S., Denny, T. N., Drosten, C., Fouchier, R. A. M., Garcia, P. J., Halfmann, P. J., Jassem, A., Jeworowski, L. M., …, & Smith, D. J. (2023). Mapping SARS-CoV-2 antigenic relationships and serological responses. Science, 382(6666). https://doi.org/10.1126/science.adj0070

Vancouver

Wilks SH, Mühlemann B, Shen X, Türeli S, LeGresley EB, Netzl A, et al. Mapping SARS-CoV-2 antigenic relationships and serological responses. Science. 2023;382(6666). doi:10.1126/science.adj0070

BibTeX
@article{Wilks2023,
  author = {Wilks, Samuel H and Mühlemann, Barbara and Shen, Xiaoying and Türeli, Sina and LeGresley, Eric B and Netzl, Antonia and Caniza, Miguela A and Chacaltana-Huarcaya, Jesus N and Corman, Victor M and Daniell, Xiaoju and Datto, Michael B and Dawood, Fatimah S and Denny, Thomas N and Drosten, Christian and Fouchier, Ron A M and Garcia, Patricia J and Halfmann, Peter J and Jassem, Agatha and Jeworowski, Lara M and Jones, Terry C and Kawaoka, Yoshihiro and Krammer, Florian and McDanal, Charlene and Pajon, Rolando and Simon, Viviana and Stockwell, Melissa S and Tang, Haili and van Bakel, Harm and Veguilla, Vic and Webby, Richard and Montefiori, David C and Smith, Derek J},
  title = {Mapping SARS-CoV-2 antigenic relationships and serological responses},
  journal = {Science},
  year = {2023},
  volume = {382},
  number = {6666},
  doi = {10.1126/science.adj0070}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche